0000000000188477

AUTHOR

José Ramón González-juanatey

showing 2 related works from this author

Mortality associated with cardiovascular disease in patients with COVID-19

2020

Introducción y objetivos: Las enfermedades cardiovasculares (ECV) se han identificado como un factor de riesgo de mal pronóstico en pacientes con infección por COVID-19. Métodos: Se realizó un metanálisis de estudios actualmente disponibles con la prevalencia de ECV en supervivientes frente a no supervivientes en pacientes con infección por COVID-19 hasta el 16 de julio de 2020. Los análisis se realizaron mediante un modelo de efectos aleatorios y sensibilidad. Se realizaron análisis para identificar posibles fuentes de heterogeneidad o evaluar los efectos de los estudios pequeños. Resultados: Se incluyó a 307.596 pacientes de 16 estudios, de los que 46.321 (15,1%) tenían ECV. La tasa de mo…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industryMortality rateEnfermedad cardiovascularCOVID-19DiseaseCardiovascular diseasemedicine.diseaseRandom effects modelArticleCoronavirusCVD cardiovascular deseaseInternal medicineDiabetes mellitusMortalidadmedicineRisk of mortalityIn patientMortalityRisk factorCardiology and Cardiovascular MedicinebusinessREC: CardioClinics
researchProduct

La fibrilación auricular permanente en las enfermedades cardiovasculares en España. Estudio CARDIOTENS 1999

2002

Introduction and objective. Atrial fibrillation is the most common arrhythmia seen in clinical practice. The objective of this study was to know the frequency of atrial fibrillation and the characteristics of patients with atrial fibrillation in the Cardiotens study. Material and method. A cross-section study with systematic selection of the study sample. All 32,051 outpatients seen on the same day by 1,159 physicians specialized in primary-care (79%) and cardiology (21%) were prospectively added to a database including history of cardiac disease (heart failure, coronary disease or atrial fibrillation), blood pressure, and ongoing treatment. Results. Atrial fibrillation was present in 25% o…

medicine.medical_specialtyDigoxinCross-sectional studybusiness.industryAtrial fibrillationmedicine.diseaseBlood pressureInternal medicineHeart failureAntithromboticEpidemiologymedicineCardiologyPopulation studycardiovascular diseasesCardiology and Cardiovascular Medicinebusinessmedicine.drugRevista Española de Cardiología
researchProduct